Patient Guide: A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 49 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04526899
Status: ACTIVE_NOT_RECRUITING
Condition: Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 49 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • San Francisco, California
  • Miami, Florida
  • • And 46 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily